Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 1001 to 1025 of 2555

TitleReference numberPublishedLast updated
Siponimod for treating secondary progressive multiple sclerosisTA656
Carfilzomib for previously treated multiple myelomaTA657
Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myelomaTA658
Magseed for locating impalpable breast cancer lesionsMIB236
NPi-200 for pupillary light reflex in critical care patientsMIB235
Human and animal bites: antimicrobial prescribingNG184
Dexcom G6 for real-time continuous glucose monitoringMIB233
Antimicrobial prescribing: imipenem with cilastatin and relebactamES30
Testing strategies for Lynch syndrome in people with endometrial cancerHTG557
Pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosisHTG558
Balloon cryoablation for squamous dysplasia of the oesophagusHTG560
Tegaderm CHG securement dressing for vascular access sitesMIB231
Volanesorsen for treating familial chylomicronaemia syndromeHST13
Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapyTA655
Heavy menstrual bleedingQS47
SEM Scanner 200 for preventing pressure ulcersHTG556
Osimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancerTA653
Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancerTA654
Rheumatoid arthritis in adults: managementNG100
Behaviour change: digital and mobile health interventionsNG183
Pembrolizumab with axitinib for untreated advanced renal cell carcinomaTA650
Naldemedine for treating opioid-induced constipationTA651
Novii Wireless Patch System for maternal and fetal monitoringMIB228
Transcranial magnetic stimulation for auditory hallucinationsHTG555
Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphomaTA649

Results per page

  1. 10
  2. 25
  3. 50
  4. All